Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.86% | 4.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.86% | 4.29% | |||
| Cost of Revenue | 9.43% | -0.23% | |||
| Gross Profit | 8.48% | 7.49% | |||
| SG&A Expenses | -11.82% | 28.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.86% | 17.14% | |||
| Operating Income | 77.86% | -240.12% | |||
| Income Before Tax | -119.93% | -2,043.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -111.92% | -2,043.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -111.92% | -2,043.43% | |||
| EBIT | 77.86% | -240.12% | |||
| EBITDA | 308.70% | -154.19% | |||
| EPS Basic | -105.06% | -1,763.12% | |||
| Normalized Basic EPS | 63.25% | -91.26% | |||
| EPS Diluted | -105.06% | -1,763.12% | |||
| Normalized Diluted EPS | 63.25% | -91.26% | |||
| Average Basic Shares Outstanding | 3.34% | 15.20% | |||
| Average Diluted Shares Outstanding | 3.34% | 15.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||